55 Metcalfe St, Suite 900, PO Box 2999, Stn D, Ottawa, ON
Year called to bar: 1992 (BC); 1993 (AB); 2001 (ON)
David Schwartz is a respected IP leader with nearly 30 years of experience in patent law in the fields of biotechnology, pharmaceuticals and chemistry as well as plant breeders’ rights. David advises on regulatory matters relating to the Patented Medicines (Notice of Compliance) Regulations, data protection under the Food and Drug Regulations and matters concerning the Patented Medicine Prices Review Board. He appears regularly in oral proceedings before the Patent Appeal Board and has handled first-to-invent conflicts under the pre-1989 Patent Act. He has testified on patent law reform before both the House of Commons Standing Committee on Industry, Science and Technology and the Senate National Finance Committee, and has lectured on patent law at Queen’s University and the University of Ottawa. In addition to being named Ottawa’s “Lawyer of the Year” in Biotechnology Law multiple times and recognized annually as one of “The Best Biotechnology Lawyers in Canada”, David is also annually listed in IAM Patents 1000, LMG Life Sciences and Managing IP’s IP Stars Handbook: Patents. Past president of the Intellectual Property Institute of Canada. BSc Hons (Genetics); LLB. Registered Patent and Trademark Agent. British Columbia Bar (1992), Alberta Bar (1993), Ontario Bar (2001).